Immuno-Biological Laboratories Co (TSE:4570) EPS (Basic) : 円20.05 (TTM As of Sep. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Immuno-Biological Laboratories Co EPS (Basic)?

Immuno-Biological Laboratories Co's basic earnings per share (Basic EPS) for the three months ended in Sep. 2024 was 円0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2024 was 円20.05.

Immuno-Biological Laboratories Co's EPS (Diluted) for the three months ended in Sep. 2024 was 円0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was 円20.04.

Immuno-Biological Laboratories Co's EPS without NRI for the three months ended in Sep. 2024 was 円0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2024 was 19.46.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Immuno-Biological Laboratories Co's highest 3-Year average EPS without NRI Growth Rate was 36.20% per year. The lowest was -210.50% per year. And the median was -15.00% per year.

Immuno-Biological Laboratories Co EPS (Basic) Historical Data

The historical data trend for Immuno-Biological Laboratories Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immuno-Biological Laboratories Co EPS (Basic) Chart

Immuno-Biological Laboratories Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EPS (Basic)

Get a 7-Day Free Trial

-76.00

-34.23

-27.78

-31.10

20.05

Immuno-Biological Laboratories Co Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24
EPS (Basic)	Get a 7-Day Free Trial															1.19	1.69	-0.67	17.84	-

Immuno-Biological Laboratories Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Immuno-Biological Laboratories Co's Basic EPS for the fiscal year that ended in Mar. 2024 is calculated as

Basic EPS (A: Mar. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(186.694	-	0)	/	9.313
	=	20.05

Immuno-Biological Laboratories Co's Basic EPS for the quarter that ended in Sep. 2024 is calculated as

Basic EPS (Q: Sep. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(0	-	0)	/	9.313
	=	0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円20.05

Immuno-Biological Laboratories Co (TSE:4570) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Immuno-Biological Laboratories Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Immuno-Biological Laboratories Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Immuno-Biological Laboratories Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immuno-Biological Laboratories Co Ltd (TSE:4570) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

1091-1 Naka Aza-Higashida, Gunma, Fujioka, JPN, 375-0005

Website

http://www.ibl-japan.co.jp

Immuno-Biological Laboratories Co Ltd focuses on research and development. It researches, develops, manufacture and supplies various immunological research reagents, and customized services. It is engaged in research and development of materials used in diagnostic products and valuable seeds and technology for protein production using transgenic silkworm cocoons, which make it possible to create valuable proteins as well as antibodies. It works on clinical reagents for cancer research. Its research scientists are producing inflammatory cytokines, growth factors & antibodies for use against these cancers.

Immuno-Biological Laboratories Co Headlines

No Headlines